77 related articles for article (PubMed ID: 20853307)
21. Structure-activity relationship study of antioxidative peptides by QSAR modeling: the amino acid next to C-terminus affects the activity.
Li YW; Li B; He J; Qian P
J Pept Sci; 2011 Jun; 17(6):454-62. PubMed ID: 21491545
[TBL] [Abstract][Full Text] [Related]
22. Structural studies of the phosphatidylinositol 3-kinase (PI3K) SH3 domain in complex with a peptide ligand: role of the anchor residue in ligand binding.
Batra-Safferling R; Granzin J; Mödder S; Hoffmann S; Willbold D
Biol Chem; 2010 Jan; 391(1):33-42. PubMed ID: 19919182
[TBL] [Abstract][Full Text] [Related]
23. [New 3D amino acid structure descriptors and its application to the polypeptide QSAR].
Ding JJ; Ding XQ; Zhao LF; Chen JS
Yao Xue Xue Bao; 2005 Apr; 40(4):340-6. PubMed ID: 16011263
[TBL] [Abstract][Full Text] [Related]
24. Differential ligand recognition by the Src and phosphatidylinositol 3-kinase Src homology 3 domains: circular dichroism and ultraviolet resonance Raman studies.
Okishio N; Tanaka T; Fukuda R; Nagai M
Biochemistry; 2003 Jan; 42(1):208-16. PubMed ID: 12515556
[TBL] [Abstract][Full Text] [Related]
25. Structure-based characterization of the binding of peptide to the human endophilin-1 Src homology 3 domain using position-dependent noncovalent potential analysis.
Fu C; Wu G; Lv F; Tian F
J Mol Model; 2012 May; 18(5):2153-61. PubMed ID: 21947444
[TBL] [Abstract][Full Text] [Related]
26. Structural basis of PxxDY motif recognition in SH3 binding.
Aitio O; Hellman M; Kesti T; Kleino I; Samuilova O; Pääkkönen K; Tossavainen H; Saksela K; Permi P
J Mol Biol; 2008 Sep; 382(1):167-78. PubMed ID: 18644376
[TBL] [Abstract][Full Text] [Related]
27. SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef.
Hiipakka M; Poikonen K; Saksela K
J Mol Biol; 1999 Nov; 293(5):1097-106. PubMed ID: 10547288
[TBL] [Abstract][Full Text] [Related]
28. Identification and specificity studies of small-molecule ligands for SH3 protein domains.
Inglis SR; Stojkoski C; Branson KM; Cawthray JF; Fritz D; Wiadrowski E; Pyke SM; Booker GW
J Med Chem; 2004 Oct; 47(22):5405-17. PubMed ID: 15481978
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
[TBL] [Abstract][Full Text] [Related]
30. Using multidimensional patterns of amino acid attributes for QSAR analysis of peptides.
Liang G; Yang L; Kang L; Mei H; Li Z
Amino Acids; 2009 Oct; 37(4):583-91. PubMed ID: 18821054
[TBL] [Abstract][Full Text] [Related]
31. Studying receptor-ligand interactions using encoded amino acid scanning.
Camarero JA; Ayers B; Muir TW
Biochemistry; 1998 May; 37(20):7487-95. PubMed ID: 9585562
[TBL] [Abstract][Full Text] [Related]
32. Amino acid conformational preferences and solvation of polar backbone atoms in peptides and proteins.
Avbelj F
J Mol Biol; 2000 Jul; 300(5):1335-59. PubMed ID: 10903873
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands.
Tiwari R; Brown A; Narramaneni S; Sun G; Parang K
Biochimie; 2010 Sep; 92(9):1153-63. PubMed ID: 20109515
[TBL] [Abstract][Full Text] [Related]
34. Examining the specificity of Src homology 3 domain--ligand interactions with alkaline phosphatase fusion proteins.
Yamabhai M; Kay BK
Anal Biochem; 1997 Apr; 247(1):143-51. PubMed ID: 9126384
[TBL] [Abstract][Full Text] [Related]
35. Rational design of specific high-affinity peptide ligands for the Abl-SH3 domain.
Pisabarro MT; Serrano L
Biochemistry; 1996 Aug; 35(33):10634-40. PubMed ID: 8718852
[TBL] [Abstract][Full Text] [Related]
36. Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.
Wu C; Ma MH; Brown KR; Geisler M; Li L; Tzeng E; Jia CY; Jurisica I; Li SS
Proteomics; 2007 Jun; 7(11):1775-85. PubMed ID: 17474147
[TBL] [Abstract][Full Text] [Related]
37. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
Liu J; Li M; Ran X; Fan JS; Song J
Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
[TBL] [Abstract][Full Text] [Related]
38. Crystal structure analysis and solution studies of human Lck-SH3; zinc-induced homodimerization competes with the binding of proline-rich motifs.
Romir J; Lilie H; Egerer-Sieber C; Bauer F; Sticht H; Muller YA
J Mol Biol; 2007 Feb; 365(5):1417-28. PubMed ID: 17118402
[TBL] [Abstract][Full Text] [Related]
39. Microexon-based regulation of ITSN1 and Src SH3 domains specificity relies on introduction of charged amino acids into the interaction interface.
Dergai M; Tsyba L; Dergai O; Zlatskii I; Skrypkina I; Kovalenko V; Rynditch A
Biochem Biophys Res Commun; 2010 Aug; 399(2):307-12. PubMed ID: 20659428
[TBL] [Abstract][Full Text] [Related]
40. Characterization of structure-antioxidant activity relationship of peptides in free radical systems using QSAR models: key sequence positions and their amino acid properties.
Li YW; Li B
J Theor Biol; 2013 Feb; 318():29-43. PubMed ID: 23127747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
